Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000926236-04-000044
Filing Date
2004-03-19
Accepted
2004-03-19 16:47:40
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K YEAR ENDED DECEMBER 31, 2003 cli03q4.txt 10-K 202785
3 SUBSIDIARIES exh21-1.txt EX-21.1 675
4 CONSENT exh23-1.txt EX-23.1 1222
5 CONSENT exh23-2.txt EX-23.2 939
6 RULE 13A-14(A) CERTIFICATION exh31-1.txt EX-31.1 3283
7 RULE 13A-14(A) CERTIFICATION exh31-2.txt EX-31.2 3335
8 SECTION 906 CERTIFICATION exh32-1.txt EX-32.1 1267
9 SECTION 906 CERTIFICATION exh32-2.txt EX-32.2 1238
  Complete submission text file 0000926236-04-000044.txt   217159
Mailing Address PO BOX 168128 IRVING TX 75016-8128
Business Address 2001 WALNUT HILL LANE IRVING TX 75038 972-518-1300
CARRINGTON LABORATORIES INC /TX/ (Filer) CIK: 0000718007 (see all company filings)

EIN.: 751435663 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10862 | Film No.: 04680482
SIC: 2834 Pharmaceutical Preparations